Distinguishing naive- from memory-derived human B cells during acute responses.
B cell
TLR
differentiation
memory
monocyte
naive
Journal
Clinical & translational immunology
ISSN: 2050-0068
Titre abrégé: Clin Transl Immunology
Pays: Australia
ID NLM: 101638268
Informations de publication
Date de publication:
2019
2019
Historique:
received:
24
06
2019
revised:
22
10
2019
accepted:
22
10
2019
entrez:
18
12
2019
pubmed:
18
12
2019
medline:
18
12
2019
Statut:
epublish
Résumé
A fundamental question in influenza research is whether antibody titre decline upon successive exposure to variant strains is consequent to recall of cross-reactive memory B cells that competitively inhibit naive B-cell responses. In connection, it is not clear whether naive and memory B cells remain phenotypically distinct acutely after activation such that they may be distinguished Here, we first compared the capacity of anti-Ig and Toll-like-receptor (TLR) 7/8 and TLR9 agonists (R848 and CpG) to augment human B-cell differentiation induced by IL-21 and sCD40L. The conditions that induced optimal differentiation were then used to compare the post-activation phenotype of sort-purified naive and memory B-cell subsets by FACS and antibody-secreting cell (ASC) ELISPOT. Sort-purified naive and memory B cells underwent robust plasmablast and ASC formation when stimulated with R848, but not CpG, and co-cultured with monocytes. This coincided with increased IL-1β and IL-6 production when B cells were co-cultured with monocytes and stimulated with R848, but not CpG. Naive B cells underwent equivalent ASC generation, but exhibited less class-switch and modulation of CD27, CD38 and CD20 expression than memory B cells after stimulation with R848 and monocytes for 6 days. Stimulation with R848, IL-21 and sCD40L in the presence of monocytes induces robust differentiation and ASC generation from both naive and memory B-cells. However, naive and memory B cells retain key phenotypic differences after activation that may facilitate
Identifiants
pubmed: 31844520
doi: 10.1002/cti2.1090
pii: CTI21090
pmc: PMC6851823
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e01090Informations de copyright
© 2019 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Immunol. 2007 Dec 1;179(11):7276-86
pubmed: 18025170
Eur J Immunol. 2007 Aug;37(8):2205-13
pubmed: 17621369
PLoS Pathog. 2008 Aug 29;4(8):e1000138
pubmed: 18769719
Eur J Immunol. 2017 Jan;47(1):131-143
pubmed: 27800605
J Immunol. 2005 Apr 1;174(7):4043-50
pubmed: 15778362
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
J Immunol. 2009 Jan 15;182(2):890-901
pubmed: 19124732
J Biol Chem. 1988 Jul 25;263(21):10262-6
pubmed: 2839482
Blood. 2003 Aug 1;102(3):956-63
pubmed: 12689944
J Immunol Methods. 2013 May 31;391(1-2):50-9
pubmed: 23454005
PLoS One. 2011 Mar 14;6(3):e17739
pubmed: 21423809
Eur J Immunol. 2006 Apr;36(4):810-6
pubmed: 16541472
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7119-24
pubmed: 19359475
Science. 2002 Dec 13;298(5601):2199-202
pubmed: 12481138
J Immunol. 2005 Feb 1;174(3):1259-68
pubmed: 15661881
J Immunol. 2009 Feb 15;182(4):1991-2001
pubmed: 19201852
J Immunol. 2007 Dec 15;179(12):8180-90
pubmed: 18056361
Cell Host Microbe. 2014 Jul 9;16(1):115-27
pubmed: 24981333
Clin Exp Immunol. 1992 Apr;88(1):75-83
pubmed: 1563109
J Immunol Methods. 2010 Jun 30;358(1-2):56-65
pubmed: 20302874
Nat Immunol. 2018 Apr;19(4):386-396
pubmed: 29556002
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
PLoS One. 2011;6(10):e25542
pubmed: 21991317
Front Immunol. 2018 Oct 12;9:2370
pubmed: 30369932
Cell Mol Immunol. 2012 Nov;9(6):434-8
pubmed: 23085951
J Immunol Methods. 2004 Mar;286(1-2):111-22
pubmed: 15087226
BMC Immunol. 2008 Jul 24;9:39
pubmed: 18652679
Blood. 2003 Jun 1;101(11):4500-4
pubmed: 12560217
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
J Immunol. 2004 May 1;172(9):5154-7
pubmed: 15100251
Blood. 2004 Jan 15;103(2):689-94
pubmed: 14512299
Curr Opin Virol. 2014 Oct;8:85-9
pubmed: 25108824
Immunity. 2018 Mar 20;48(3):584-598.e5
pubmed: 29548673
Immunology. 2018 Mar;153(3):357-367
pubmed: 28940186
J Leukoc Biol. 1995 Sep;58(3):365-72
pubmed: 7665993
Int Immunol. 2006 May;18(5):701-12
pubmed: 16569679
Curr Opin Virol. 2017 Feb;22:105-111
pubmed: 28088686
J Exp Med. 2017 Nov 6;214(11):3207-3217
pubmed: 28899868
Nat Rev Immunol. 2009 Jul;9(7):491-502
pubmed: 19521398
Clin Microbiol Rev. 2017 Oct;30(4):991-1014
pubmed: 28855265
J Immunol. 2008 Feb 15;180(4):2117-24
pubmed: 18250417
J Immunol. 2003 Jan 15;170(2):686-94
pubmed: 12517929